| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|
| ABCB1 | 40 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | Afatinib | qRT-PCR followed by SFA | NA | 0.2 | 0.0604 | 29532558
|
| ABCB1 | 40 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SP assay followed by invasion assay and RT-PCR | NA | 0.2 | 0.0604 | 17510412
|
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SP assay followed by invasion assay and RT-PCR | NA | 0.2 | 0.1739 | 17510412
|
| KLF4 | 6348 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.0891 | 33670440
|
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.5461 | 33670440
|
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.6448 | 33670440
|
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.5695 | 33670440
|
| ALDH1A1 | 402 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.12 | 0.684 | 25881239
|
| EPCAM | 11529 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.12 | 0.211 | 25881239
|
| ALCAM | 400 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | FACs followed by SFA | NA | 0.12 | 0.0583 | 33670440
|
| ALCAM | 400 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | Curcumin+Cisplatin | FACs followed by SFA | NA | 0.12 | 0.0583 | 26531053
|
| ALCAM | 400 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | FACs followed by SFA | NA | 0.12 | 0.0583 | 29868483
|
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by ALDEFLUOR assay | NA | 0.12 | 0.684 | 31466290
|
| EPCAM | 11529 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | FACs followed by SFA | NA | 0.12 | 0.211 | 33670440
|
| EPCAM | 11529 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | Curcumin+Cisplatin | FACs followed by SFA | NA | 0.12 | 0.211 | 26531053
|
| EPCAM | 11529 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | FACs followed by SFA | NA | 0.12 | 0.211 | 29868483
|
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | FACs | NA | 0.12 | 0.7582 | 34827096
|
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | FACs followed by SFA | NA | 0.12 | 0.7582 | 31466290
|
| AASS | 17366 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ABCA12 | 14637 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| ABLIM1 | 78 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ABR | 81 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ACAT2 | 94 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ACER3 | 16066 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ACO1 | 117 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ACOT7 | 24157 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ACOT9 | 17152 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ACP6 | 29609 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| ACSBG1 | 29567 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ACSL1 | 3569 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| ACSL4 | 3571 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ACSS3 | 24723 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ACTN1 | 163 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ACTR1A | 167 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ACTR3B | 17256 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ADAM28 | 206 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ADAMTS1 | 217 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ADAMTS3 | 219 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ADAMTS6 | 222 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ADGRF1 | 18990 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| ADGRL2 | 18582 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ADGRV1 | 17416 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ADH5 | 253 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ADH7 | 256 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ADORA2B | 264 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| AFAP1-AS1 | 28141 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| AFAP1L2 | 25901 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| AGR2 | 328 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25881239
|
| AJUBA | 20250 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| AK4 | 363 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| AKR1C1 | 384 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0085 | 25881239
|
| AKR1C2 | 385 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25881239
|
| AKR1E2 | 23437 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| AKT3 | 393 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ALDH1A3 | 409 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0201 | 25881239
|
| AMOTL1 | 17811 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| AMY1A | 474 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| AMY1A | 474 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| AMY1B | 475 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| AMY1B | 475 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| AMY1C | 476 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| AMY1C | 476 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| AMY2A | 477 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| AMY2A | 477 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| AMY2B | 478 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| AMY2B | 478 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| AMY2B | 478 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ANK2 | 493 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ANKRD22 | 28321 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ANKRD31 | 26853 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ANO1 | 21625 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ANO4 | 23837 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ANPEP | 500 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0117 | 25881239
|
| ANTXR2 | 21732 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| ANXA6 | 544 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| ANXA8 | 546 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ANXA8L1 | 23334 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ANXA8L1 | 23334 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ANXA8L1 | 23334 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ANXA9 | 547 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| AP2M1 | 564 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| APBB2 | 582 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| APOBEC3C | 17353 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| APOD | 612 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| AREG | 651 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| AREG | 651 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| ARFGEF3 | 21213 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ARGLU1 | 25482 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ARHGAP1 | 673 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ARHGAP10 | 26099 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ARHGAP23 | 29293 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ARHGAP29 | 30207 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ARHGAP32 | 17399 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| ARHGAP42 | 26545 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ARHGAP42 | 26545 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ARHGDIB | 679 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| ARHGEF10 | 14103 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| ARHGEF38 | 25968 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ARHGEF9 | 14561 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ARID3B | 14350 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ARID4A | 9885 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ARL17A | 24096 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ARL17A | 24096 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ARL17A | 24096 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ARL17B | 32387 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ARL17B | 32387 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ARL17B | 32387 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ARL4C | 698 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ARL4D | 656 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ARNTL2 | 18984 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ARPP19 | 16967 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ARPP19 | 16967 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ARSJ | 26286 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ARSK | 25239 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ATP10D | 13549 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ATP13A3 | 24113 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ATP1B3 | 806 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ATP6V0D1 | 13724 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ATP6V1D | 13527 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ATP7A | 869 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ATP7B | 870 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ATP8A1 | 13531 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ATP9A | 13540 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| B3GNT5 | 15684 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| B4GALT6 | 929 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| BAG3 | 939 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| BCAR3 | 973 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| BCAS1 | 974 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| BCAS2 | 975 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| BCAT1 | 976 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| BCL2A1 | 991 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| BCL7A | 1004 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| BCL9 | 1008 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| BFAR | 17613 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| BHLHE41 | 16617 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| BLOC1S2 | 20984 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| BMP6 | 1073 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| BNC1 | 1081 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| BNIP3 | 1084 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| BPIFB1 | 16108 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| BPNT1 | 1096 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| BTBD10 | 21445 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| C11ORF24 | 1174 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| C11ORF54 | 30204 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25881239
|
| C21ORF91 | 16459 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| C2CD5 | 29062 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| C2ORF15 | 28436 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| C3 | 1318 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| CA2 | 1373 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CABLES1 | 25097 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| CABYR | 15569 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CACNA1D | 1391 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CACNA2D1 | 1399 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25881239
|
| CACNB4 | 1404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| CADPS2 | 16018 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| CAMK1D | 19341 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| CAP1 | 20040 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CAPRIN2 | 21259 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CASD1 | 16014 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CASP4 | 1505 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CAV1 | 1527 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0117 | 25881239
|
| CAV2 | 1528 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
| CAVIN3 | 9400 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CCBE1 | 29426 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CCDC125 | 28924 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| CCDC125 | 28924 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| CCDC169 | 34361 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CCDC50 | 18111 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CCL20 | 10619 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
| CCND2 | 1583 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CCSER1 | 29349 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CD109 | 21685 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| CD274 | 17635 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CD302 | 30843 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| CD44 | 1681 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 1 | 25881239
|
| CD47 | 1682 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| CD59 | 1689 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CD72 | 1696 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CD99 | 7082 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CD99 | 7082 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CDC20 | 1723 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CDC25A | 1725 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CDC42EP3 | 16943 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| CDC6 | 1744 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CDCP1 | 24357 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CDH11 | 1750 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| CDH13 | 1753 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CDH2 | 1759 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0085 | 25881239
|
| CDH26 | 15902 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| CDH3 | 1762 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| CDK17 | 8750 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CDK6 | 1777 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CDKN1A | 1784 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| CDKN1B | 1785 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CDKN2B-AS1 | 34341 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| CDRT1 | 14379 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CDRT1 | 14379 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CDRT1 | 14379 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CEACAM5 | 1817 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| CEACAM6 | 1818 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| CENPW | 21488 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CEP170 | 28920 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CFAP20DC | 24763 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| CFAP251 | 28506 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| CGN | 17429 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| CHD6 | 19057 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| CHD7 | 20626 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CHRNB1 | 1961 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| CHST11 | 17422 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| CITED2 | 1987 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| CKAP2L | 26877 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CLCA2 | 2016 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CLCC1 | 29675 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CLDN10 | 2033 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CLDN10 | 2033 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| CLDN11 | 8514 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| CLDN4 | 2046 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| CLDND1 | 1322 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CLEC2D | 14351 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| CLGN | 2060 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CLMP | 24039 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| CLSPN | 19715 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CLSTN1 | 17447 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CLTB | 2091 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CMBL | 25090 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CNN2 | 2156 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CNN3 | 2157 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CNTN3 | 2173 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| COBL | 22199 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| COL12A1 | 2188 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| COL17A1 | 2194 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| CORO1C | 2254 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CORO2A | 2255 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| COTL1 | 18304 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CP | 2295 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| CPA4 | 15740 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| CPE | 2303 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| CPM | 2311 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| CPOX | 2321 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CPOX | 2321 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CRACR2A | 28657 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CRACR2A | 28657 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CREB3L1 | 18856 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| CREB5 | 16844 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CREBZF | 24905 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| CRSP8P | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CRYBG1 | 356 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CSAG2 | 16847 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CSAG3 | 26237 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CSRP1 | 2469 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| CSTA | 2481 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| CTDSPL | 37294 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| CTNNAL1 | 2512 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CTNNB1 | 2514 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0647 | 25881239
|
| CTPS1 | 2519 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CTSB | 2527 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| CTSC | 2528 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| CTTNBP2NL | 25330 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| CXCL1 | 4602 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| CXCL17 | 19232 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| CXCL2 | 4603 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
| CXCL5 | 10642 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| CXXC5 | 26943 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| CYLD | 2584 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| CYP1B1 | 2597 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25881239
|
| CYP2C19 | 2621 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| CYP2C8 | 2622 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| CYR61 | 2654 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| DAB2 | 2662 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| DAPP1 | 16500 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| DCBLD2 | 24627 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| DCLK1 | 2700 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0159 | 25881239
|
| DCLRE1B | 17641 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| DDAH1 | 2715 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| DDHD1 | 19714 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| DDX3Y | 2699 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| DDX58 | 19102 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| DENND11 | 29472 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| DENND1B | 28404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| DENND1B | 28404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| DENND2C | 24748 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| DENND2C | 24748 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| DEPTOR | 22953 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| DFNA5 | 2810 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| DGKA | 2849 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| DHRS1 | 16445 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| DHRS9 | 16888 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25881239
|
| DIAPH2 | 2877 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| DIPK1A | 32213 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| DKK1 | 2891 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| DKK3 | 2893 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| DLG3 | 2902 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| DLG5 | 2904 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| DMKN | 25063 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| DNAH14 | 2945 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| DNMBP | 30373 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| DOP1B | 1291 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| DPP10 | 20823 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| DSC3 | 3037 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| DSE | 21144 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| DSG3 | 3050 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| DTNA | 3057 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| DUSP11 | 3066 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| DUSP6 | 3072 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| DUSP7 | 3073 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| DUXAP9 | 32188 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| DUXAP9 | 32188 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| DYNC1LI1 | 18745 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| DZIP1 | 20908 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| DZIP1 | 20908 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| E2F7 | 23820 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| EBP | 3133 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| EBPL | 18061 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| EDEM1 | 18967 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| EDNRA | 3179 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| EEA1 | 3185 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| EFEMP1 | 3218 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| EFNB1 | 3226 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| EGF | 3229 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| EGFR | 3236 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
| EGR2 | 3239 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| EHD2 | 3243 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| EHD4 | 3245 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| EID3 | 32961 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| EIF4E3 | 31837 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ELAPOR1 | 29618 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| ELAPOR2 | 21945 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ELF3 | 3318 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| ELF5 | 3320 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ELK3 | 3325 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ELL2 | 17064 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ELOF1 | 28691 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ELOVL1 | 14418 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ELP1 | 5959 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| EMB | 30465 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| EMC1 | 28957 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| EMP2 | 3334 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ENPEP | 3355 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ENPP1 | 3356 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| ENTPD3 | 3365 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ENTPD7 | 19745 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| EOGT | 28526 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| EPB41 | 3377 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| EPHX1 | 3401 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| EPS8 | 3420 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ERAP1 | 18173 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ERAP2 | 29499 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ERBB3 | 3431 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| ERC1 | 17072 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ERC2 | 31922 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ERCC6 | 3438 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| EREG | 3443 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ERLIN1 | 16947 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ESYT1 | 29534 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ETNK2 | 25575 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ETNPPL | 14404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ETS1 | 3488 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ETV1 | 3490 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| EWSR1 | 3508 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| EXOC2 | 24968 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| EXOC4 | 30389 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| EXOC6B | 17085 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| EXPH5 | 30578 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| EXT1 | 3512 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| EXT2 | 3513 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| EXTL3 | 3518 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| EZH2 | 3527 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0074 | 25881239
|
| F3 | 3541 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| F5 | 3542 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| F8A1 | 3547 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| F8A2 | 31849 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| F8A3 | 31850 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| FAAH2 | 26440 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| FABP6 | 3561 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| FADS2 | 3575 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| FAM122B | 30490 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| FAM126A | 24587 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| FAM184A | 20991 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| FAM185A | 22412 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| FAM214A | 25609 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| FAM36A | 26970 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| FAM83B | 21357 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| FAR2 | 25531 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| FAS | 11920 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| FAT1 | 3595 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| FAT2 | 3596 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| FAT4 | 23109 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| FAXDC2 | 1334 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| FBN2 | 3604 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| FBXL2 | 13598 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| FBXW10 | 1211 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| FBXW10 | 1211 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| FBXW10 | 1211 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| FER | 3655 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| FER1L6 | 28065 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| FERMT1 | 15889 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| FEZ1 | 3659 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| FGF11 | 3667 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| FGF5 | 3683 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| FGFBP1 | 19695 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| FGFR2 | 3689 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| FHIT | 3701 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| FHL1 | 3702 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| FHOD3 | 26178 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| FJX1 | 17166 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| FKBP15 | 23397 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| FKBP5 | 3721 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| FLI1 | 3749 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| FLII | 3750 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| FLNB | 3755 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| FLRT2 | 3761 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| FMO5 | 3773 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| FOCAD | 23377 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| FOS | 3796 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| FOXA1 | 5021 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| FOXP1 | 3823 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| FOXP2 | 13875 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| FRK | 3955 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| FRMD4B | 24886 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| FRMD6 | 19839 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| FRMPD3 | 29382 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| FRY | 20367 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| FSCN1 | 11148 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| FSIP2 | 21675 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| FSIP2 | 21675 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| FST | 3971 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| FSTL1 | 3972 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| FTL | 3999 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| FTSJ1 | 13254 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| FUT11 | 19233 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| FXYD5 | 4029 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| FZD5 | 4043 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| FZD6 | 4044 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| G0S2 | 30229 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| G6PD | 4057 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| GAB2 | 14458 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| GABPB2 | 28441 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| GABRA3 | 4077 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GALNT12 | 19877 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| GALNT13 | 23242 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| GALNT14 | 22946 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| GAREM1 | 26136 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GBF1 | 4181 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| GBP1 | 4182 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| GBP3 | 4184 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| GBP3 | 4184 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| GBP6 | 25395 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| GCA | 15990 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GCNT4 | 17973 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| GDPD3 | 28638 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| GINM1 | 21074 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| GIT2 | 4273 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| GJB2 | 4284 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| GJB5 | 4287 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| GLB1 | 4298 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| GLB1L2 | 25129 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GLCCI1 | 18713 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| GLI3 | 4319 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| GLIPR1 | 17001 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| GM2A | 4367 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| GNA15 | 4383 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| GNAI2 | 4385 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| GNAI3 | 4387 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| GNB4 | 20731 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| GNG4 | 4407 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| GNPTAB | 29670 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| GPAM | 24865 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| GPD1L | 28956 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GPR141 | 19997 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| GPR18 | 4472 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GPR87 | 4538 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| GPSM2 | 29501 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| GPX3 | 4555 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| GRB7 | 4567 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| GRHL1 | 17923 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| GRK5 | 4544 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| GSDMC | 7151 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| GSE1 | 28979 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GSR | 4623 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| GSTA1 | 4626 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| GSTM1 | 4632 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| GTF3A | 4662 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GUCY1A1 | 4685 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GUCY1B2 | 4686 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GUSBP1 | 13670 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| GUSBP2 | 18792 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GUSBP2 | 18792 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GUSBP2 | 18792 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GUSBP3 | 37301 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GUSBP3 | 37301 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| GYS1 | 4706 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| H1-0 | 4714 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| H1-1 | 4715 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| H2BC12 | 13954 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| H2BC18 | 24700 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| H2BC18 | 24700 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| H2BC21 | 4760 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| H2BC21 | 4760 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| H2BP1 | 20560 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| H2BP1 | 20560 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| H3-3A | 4764 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| H4C14 | 4794 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| H4C15 | 29607 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| H4C8 | 4788 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| HACD4 | 20920 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| HARS1 | 4816 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| HBEGF | 3059 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| HCFC2 | 24972 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| HCLS1 | 4844 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| HEG1 | 29227 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| HEPHL1 | 30477 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| HERC3 | 4876 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| HERC6 | 26072 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| HLA-A | 4931 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| HLA-J | 4967 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| HMCES | 24446 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| HMGA2 | 5009 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| HMGN5 | 8013 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| HMOX2 | 5014 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| HNF4G | 5026 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| HNMT | 5028 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| HNRNPU | 5048 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| HOMER1 | 17512 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| HOOK1 | 19884 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| HOXB2 | 5113 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| HPGD | 5154 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| HTRA1 | 9476 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ICA1 | 5343 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| IDH3A | 5384 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| IDS | 5389 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| IER3 | 5392 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| IER3 | 5392 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| IER3 | 5392 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| IFFO2 | 27006 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| IFI16 | 5395 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| IFI44 | 16938 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| IFITM3 | 5414 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| IFNGR1 | 5439 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| IFT57 | 17367 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| IGF2 | 5466 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| IGF2BP2 | 28867 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| IGFBP7 | 5476 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| IGSF3 | 5950 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| IKBIP | 26430 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| IKZF2 | 13177 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| IKZF3 | 13178 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| IL16 | 5980 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| IL1A | 5991 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| IL1B | 5992 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
| IL1RAP | 5995 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| IL20RB | 6004 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| IL31RA | 18969 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| IL4R | 6015 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| IL7R | 6024 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| IL8 | 6025 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0159 | 25881239
|
| ILK | 6040 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| INHBA | 6066 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| INPP5D | 6079 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| INPP5F | 17054 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| INS-IGF2 | 33527 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| IPO11 | 20628 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| IQCA1 | 26195 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| IQGAP1 | 6110 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| IQGAP2 | 6111 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| IRAK3 | 17020 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| IRF6 | 6121 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| IRS1 | 6125 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ISL1 | 6132 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ITGA2 | 6137 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0106 | 25881239
|
| ITGA3 | 6139 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ITGA5 | 6141 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ITGA6 | 6142 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0265 | 25881239
|
| ITGAV | 6150 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| ITGB4 | 6158 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
| ITGB6 | 6161 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| ITGB8 | 6163 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| ITGBL1 | 6164 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ITPR2 | 6181 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| JAG1 | 6188 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0117 | 25881239
|
| JARID2 | 6196 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| JPX | 37191 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| KATNAL1 | 28361 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| KCNG3 | 18306 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| KCNJ15 | 6261 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| KCNK2 | 6277 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| KCNMA1 | 6284 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| KCNRG | 18893 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| KCNS3 | 6302 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| KDELC2 | 28496 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| KDR | 6307 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| KIAA0040 | 28950 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| KIAA0930 | 1314 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| KIAA1217 | 25428 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| KIAA1549 | 22219 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| KIAA1614 | 29327 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| KIAA1958 | 23427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| KIF13A | 14566 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| KIF13B | 14405 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| KIF20B | 7212 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| KIF23 | 6392 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| KIF2A | 6318 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| KIF3A | 6319 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| KIRREL1 | 15734 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| KLF12 | 6346 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| KLF6 | 2235 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| KLF7 | 6350 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| KLHDC2 | 20231 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| KLHL23 | 27506 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| KLRF1 | 13342 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| KPNA6 | 6399 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| KRR1 | 5176 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| KRT14 | 6416 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| KRT17 | 6427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| KRT17 | 6427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| KRT17 | 6427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| KRT4 | 6441 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| KRT5 | 6442 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25881239
|
| KRT6A | 6443 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| KRT6A | 6443 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| KRT6B | 6444 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| KRT6B | 6444 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| KRT6C | 20406 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| LAMA3 | 6483 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| LAMB3 | 6490 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| LAMC2 | 6493 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| LAPTM4B | 13646 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| LAPTM5 | 29612 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| LCN2 | 6526 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| LCP1 | 6528 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| LDLR | 6547 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| LEF1 | 6551 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| LGALS1 | 6561 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| LHFP | 6586 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| LIFR | 6597 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| LIMA1 | 24636 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| LIMCH1 | 29191 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| LINC01006 | 48971 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| LIPG | 6623 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| LIX1L | 28715 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| LLPH | 28229 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| LMO7 | 6646 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| LNPEP | 6656 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| LOC344967 | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| LOC728392 | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| LONRF3 | 21152 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| LOXL2 | 6666 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| LPAR1 | 3166 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| LPAR3 | 14298 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| LPCAT2 | 26032 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| LPXN | 14061 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| LRRC37A2 | 32404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| LRRC37A2 | 32404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| LRRC37A2 | 32404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| LRRC37A3 | 32427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| LRRC37A3 | 32427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| LRRC37A3 | 32427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| LRRC37A4P | 25479 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| LRRC37A4P | 25479 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| LRRC8A | 19027 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| LRRC8C | 25075 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| LRRCC1 | 29373 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| LTBP1 | 6714 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| LUZP1 | 14985 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| LY75 | 6729 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| LY75 | 6729 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| LYST | 1968 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| MACsC1 | 30215 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| MACsO1 | 25572 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MACsROD2 | 16126 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| MAGI1 | 946 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| MAL2 | 13634 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| MAOA | 6833 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MAP4K4 | 6866 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MAP4K5 | 6867 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MAPK10 | 6872 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| MAPK6 | 6879 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MAPKAPK3 | 6888 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| MBIP | 20427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| MBNL2 | 16746 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| MBOAT2 | 25193 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MBTD1 | 19866 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| MCAM | 6934 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| MCC | 6935 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| MCCC1 | 6936 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| MCL1 | 6943 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| MCTP1 | 26183 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| MDGA2 | 19835 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ME1 | 6983 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| MED27 | 2377 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MEF2C | 6996 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| MERTK | 7027 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| MEST | 7028 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| MFAP5 | 29673 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MFN2 | 16877 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MFSD14B | 23376 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MFSD2A | 25897 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MGAT4A | 7047 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| MGC70870 | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| MICAL2 | 24693 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| MICALCL | 24693 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MIEN1 | 28230 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| MINDY1 | 25648 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| MIPOL1 | 21460 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| MIR198 | 31570 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MIR205 | 31583 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| MITF | 7105 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| MMP1 | 7155 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MMP10 | 7156 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MMP14 | 7160 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MMP2 | 7166 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MOB3B | 23825 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MORC3 | 23572 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MPP1 | 7219 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| MPZL2 | 3496 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| MRPL30 | 14036 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| MSANTD3-TMEFF1 | 38838 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MSN | 7373 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| MT1DP | 7396 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MT1E | 7397 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MT1G | 7399 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MT1L | 7404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MT1P3 | 16120 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MT1X | 7405 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| MT2A | 7406 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MT2A | 7406 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MT2A | 7406 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MTAP | 7413 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| MTRF1 | 7469 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| MTSS1 | 20443 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| MUC5B | 7516 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| MX2 | 7533 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| MXI1 | 7534 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| MYB | 7545 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| MYBL1 | 7547 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MYH11 | 7569 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MYO1B | 7596 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| MYO5A | 7602 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| MYO5B | 7603 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| MYOF | 3656 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| NAALADL2 | 23219 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| NABP1 | 26232 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| NAPEPLD | 21683 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| NAV1 | 15989 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| NAV3 | 15998 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| NBEA | 7648 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| NBR2 | 20691 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| NBR2 | 20691 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| NBR2 | 20691 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| NCEH1 | 29260 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| NDE1 | 17619 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| NDRG1 | 7679 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| NDST1 | 7680 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| NDUFA3 | 7686 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| NEB | 7720 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| NEBL | 16932 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| NECAP2 | 25528 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| NECTIN1 | 9706 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| NECTIN3 | 17664 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| NEDD1 | 7723 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| NEDD4 | 7727 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| NEK1 | 7744 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| NEK5 | 7748 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| NEU1 | 7758 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| NEU1 | 7758 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| NEXN | 29557 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| NFATC2 | 7776 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| NFE2L1 | 7781 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| NFIX | 7788 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| NFKB1 | 7794 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| NFKBIZ | 29805 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| NIPAL1 | 27194 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| NIPAL4 | 28018 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| NIPSNAP3A | 23619 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| NLRP1 | 14374 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| NPC1 | 7897 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| NPNT | 27405 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| NPR3 | 7945 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| NPR3 | 7945 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| NRG1 | 7997 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| NRG1 | 7997 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| NRN1 | 17972 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| NRP2 | 8005 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| NSUN7 | 25857 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| NT5DC3 | 30826 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| NTAN1 | 29909 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| NTM | 17941 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| NUDT11 | 18011 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| NUP210 | 30052 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| NXT2 | 18151 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| OAT | 8091 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| OCIAD2 | 28685 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| OCLN | 8104 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ODR4 | 24299 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| OGT | 8127 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| OPHN1 | 8148 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| OPTN | 17142 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| OR13H1 | 17142 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| OR7E14P | 8234 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ORMDL2 | 8385 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| OSBPL1A | 16395 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| OSBPL8 | 16398 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| OXCT1 | 8527 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| OXSR1 | 8508 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| P4HA1 | 8546 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| P4HA2 | 8547 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PAK1 | 8590 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| PAK2 | 8591 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PAK3 | 8592 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PALMD | 15846 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| PANX1 | 8599 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PARD3B | 16051 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PARVA | 24536 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PAX9 | 8623 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| PBOV1 | 21079 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PBX3 | 8634 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PCDH20 | 14257 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| PCDHB2 | 8687 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| PCDHB5 | 8690 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PCID2 | 25653 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PCMT1 | 8728 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PCMTD2 | 15882 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| PCYT1A | 8754 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PDCD1LG2 | 18731 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PDE3B | 8779 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| PDE4DIP | 15580 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| PDE5A | 8784 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| PDGFA | 8799 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PDGFC | 8801 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PDLIM1 | 2067 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PDPN | 29602 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| PDXDC1 | 28995 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PECR | 18281 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PELI2 | 8828 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PEX1 | 8850 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PFDN1 | 8866 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PGAM1 | 8888 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| PGAM1 | 8888 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| PGAM1 | 8888 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| PGAM4 | 21731 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PGAM4 | 21731 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PGAM4 | 21731 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PGAP3 | 23719 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PGBD3 | 19400 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PGM3 | 8907 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PHLDA1 | 8933 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| PHLDB2 | 29573 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| PHOSPHO2 | 28316 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| PI4K2A | 30031 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PIK3C2B | 8972 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| PINK1 | 14581 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PIP4K2C | 23786 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PIP4P2 | 25452 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PKP1 | 9023 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| PLA2G10 | 9029 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PLAT | 9051 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| PLAU | 9052 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| PLAUR | 9053 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0085 | 25881239
|
| PLCB1 | 15917 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PLEK2 | 19238 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PLEKHA1 | 14335 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PLEKHA6 | 17053 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PLEKHA7 | 27049 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| PLEKHG1 | 20884 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| PLOD1 | 9081 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| PLOD2 | 9082 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
| PLXNA1 | 9099 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PLXNA2 | 9100 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PODXL | 9171 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| POLH | 9181 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| POLR2A | 9187 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| POLR3A | 30074 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PORCN | 17652 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| POTEB | 33734 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| POTEE | 33895 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| POTEE | 33895 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| POTEF | 33895 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| POTEF | 33905 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| POTEG | 33896 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| POTEG | 33896 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| POTEH | 133 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| POTEM | 37096 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| POU6F2 | 21694 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PPARD | 9235 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PPFIBP2 | 9250 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| PPP1R18 | 29413 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PPP1R9A | 14946 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PPP2R3A | 9307 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PPP3CB | 9315 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PPP3CC | 9316 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PPP4R1 | 9320 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PPP4R4 | 23788 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PREP | 9358 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PREX2 | 22950 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PRICKLE1 | 17019 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PRKAA2 | 9377 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PRKAG1 | 9385 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PRKAR2B | 9392 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PRKD1 | 9407 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| PRKG1 | 9414 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PRSS1 | 9475 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| PRSS1 | 9475 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| PRSS2 | 9483 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| PRSS2 | 9483 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| PRSS2 | 9483 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| PRSS3 | 9486 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PRSS3 | 9486 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PRSS3 | 9486 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PRSS3P2 | 43788 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PRSS48 | 24635 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PRTFDC1 | 23333 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| PRXL2C | 16881 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PSMA5 | 9534 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| PSMB7 | 9544 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PSMD2 | 9559 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PSTPIP2 | 9581 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PTAFR | 9582 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PTGFRN | 9601 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PTGR2 | 20149 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| PTGS2 | 9605 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| PTH2R | 9609 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| PTHLH | 9607 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| PTK2B | 9612 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PTPN14 | 9647 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PTPRE | 9669 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| PTPRG | 9671 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PTPRK | 9674 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| PTPRZ1 | 9685 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PTTG1IP | 13524 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| PXDN | 14966 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| PYGL | 9725 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| QPCT | 9753 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| RAB11FIP1 | 30265 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| RAB18 | 14244 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RAB27B | 9767 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| RAB31 | 9771 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| RAB38 | 9776 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RAB3B | 9778 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RAC2 | 9802 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RALGAPA2 | 16207 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| RAPGEF5 | 16862 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| RAPGEFL1 | 17428 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| RARB | 9865 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| RASA2 | 9872 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RASA4 | 23181 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| RASEF | 26464 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| RASGEF1B | 24881 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| RASGRP3 | 14545 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| RASSF6 | 20796 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| RASSF8 | 13232 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| RBM47 | 30358 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| RBMS2 | 9909 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RBP1 | 9919 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| RC3H2 | 21461 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| RDH10 | 19975 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| REEP3 | 23711 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| REEP3 | 23711 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| REPIN1 | 17922 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| RERG | 15980 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| REXO2 | 17851 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RFTN1 | 30278 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| RGL1 | 30281 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| RGS2 | 9998 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| RGS5 | 10001 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| RHOC | 669 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| RHPN2 | 19974 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| RIC8A | 29550 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RIMS2 | 17283 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| RIT1 | 10023 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| RN7SK | 10037 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| RNF11 | 10056 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RNF152 | 26811 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RNF19B | 26886 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RNF213 | 14539 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| RNF213 | 14539 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| RNF217 | 21487 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| RNFT2 | 25905 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| RNU1-1 | 10120 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| RNU1-1 | 10120 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| RNU1-1 | 10120 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| RNU1-1 | 10120 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| RNU1-1 | 10120 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| RNY4P8 | 34057 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| RP2 | 10274 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RPL13A | 10304 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25881239
|
| RPP14 | 30327 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RPPH1 | 19273 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| RPS4Y1 | 10425 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RRAGC | 19902 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RRAGD | 19903 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| RSBN1L | 24765 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| RSU1 | 10464 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| RTKN2 | 19364 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| S100A14 | 18901 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| S100A16 | 20441 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| S100A2 | 10492 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| S100A8 | 10498 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| S100P | 10504 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0106 | 25881239
|
| SAA1 | 10513 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SACS | 10519 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| SAMD12 | 31750 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SAMD9 | 1348 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SAR1A | 10534 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SATB1 | 10541 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SATB2 | 21637 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SCAMP2 | 10564 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SCARNA9 | 32566 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SCCPDH | 24275 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SCEL | 10573 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| SCNN1A | 10599 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25881239
|
| SCPEP1 | 29507 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SCYL2 | 19286 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SDC2 | 10659 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| SEC13 | 10697 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SEC14L2 | 10699 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SEC22C | 16828 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SELENON | 15999 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SELENOP | 10751 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| SELENOW | 10752 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SEMA3A | 10723 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SEMA3E | 10727 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SEMA6D | 16770 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| SEMA7A | 10741 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| SERINC2 | 23231 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| SERPINB2 | 8584 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| SERPINB5 | 8949 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| SERPINB8 | 8952 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SERPINE1 | 8583 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| SERPINE2 | 8951 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| SERPINF1 | 8824 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SERPINH1 | 1546 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| SESN1 | 21595 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SESTD1 | 18379 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SFN | 10773 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| SFXN1 | 16085 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SGCB | 10806 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SGK1 | 10810 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| SH3BGRL | 10823 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| SH3BGRL2 | 15567 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SH3GLB1 | 10833 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SH3PXD2A | 23664 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| SH3RF2 | 26299 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SHC1 | 10840 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SHCBP1 | 29547 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SHMT2 | 10852 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| SIDT1 | 25967 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SIKE1 | 26119 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SIRPA | 9662 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SKAP2 | 15687 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SLAIN1 | 26387 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SLC10A7 | 23088 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SLC15A4 | 23090 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SLC16A14 | 26417 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SLC16A2 | 10923 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SLC1A1 | 10939 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SLC20A1 | 10946 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SLC20A2 | 10947 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SLC25A21 | 14411 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SLC25A30 | 27371 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SLC26A2 | 10994 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SLC30A4 | 11015 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SLC30A7 | 19306 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SLC35D1 | 20800 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SLC37A2 | 20644 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SLC40A1 | 10909 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SLC41A2 | 31045 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SLC43A3 | 17466 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SLC44A4 | 13941 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SLC44A4 | 13941 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SLC44A5 | 28524 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SLC4A7 | 11033 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SLC6A11 | 11044 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SLC6A6 | 11052 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SLC8A1 | 11068 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| SLC9A1 | 11071 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SLCO1A2 | 10956 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SLCO3A1 | 10952 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SLCO4C1 | 23612 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SLFN13 | 26481 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SLPI | 11092 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0074 | 25881239
|
| SLX4IP | 16225 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SMAD9 | 6774 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SMARCD1 | 11106 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SMIM14 | 27321 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SMN1 | 11117 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SMN1 | 11117 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SMN1 | 11117 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SMURF2 | 16809 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SNAI2 | 11094 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0159 | 25881239
|
| SNAP23 | 11131 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SNCA | 11138 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SNORA50A | 32643 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SNORA71A | 10232 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SNORD13 | 32711 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SNORD13P2 | 10111 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SNORD33 | 10160 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SNORD4B | 10098 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SNORD5 | 32702 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SNRK | 30598 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SNTB1 | 11168 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SNX10 | 14974 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SOHLH2 | 26026 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SORBS2 | 24098 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| SORD | 11184 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SOWAHC | 26149 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| SP140L | 25105 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPANXA1 | 11218 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPANXA1 | 11218 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPANXA2 | 14328 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPANXA2 | 14331 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPANXC | 14331 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPANXC | 14331 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPANXC | 14331 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPANXC | 14331 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPANXC | 14331 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPANXD | 14332 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPANXD | 14332 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPANXD | 14332 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPARC | 11219 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| SPCS3 | 26212 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SPDYE1 | 16408 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SPDYE1 | 16408 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SPDYE1 | 16408 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SPDYE2 | 33841 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPDYE5 | 35464 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPDYE5 | 35464 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPDYE5 | 35464 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPDYE7P | 35466 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPDYE7P | 35466 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPDYE7P | 35466 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPIN3 | 27272 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SPP1 | 11255 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| SPRR1B | 11260 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| SPTLC3 | 16253 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| SPTSSB | 24045 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SQOR | 20390 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| SREK1IP1 | 26716 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SRPX | 11309 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| SRXN1 | 16132 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| SSPN | 11322 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SSR3 | 11325 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ST6GALNAC2 | 10867 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| STARD4 | 18058 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| STARD5 | 18065 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| STAT6 | 11368 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| STC1 | 11373 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| STEAP1 | 11378 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25881239
|
| STEAP2 | 17885 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| STEAP4 | 21923 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| STK10 | 11388 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| STK17A | 11395 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| STOM | 3383 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| STX2 | 3403 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| STX3 | 11438 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| STX6 | 11441 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| STXBP1 | 11444 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| STXBP5 | 19665 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SULF2 | 20392 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| SURF4 | 11476 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| SVIP | 25238 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SYCP2 | 11490 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| SYCP2L | 21537 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| SYDE2 | 25841 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SYT14 | 23143 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| SYTL5 | 15589 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| TAF1D | 28759 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| TAGLN3 | 29868 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TAOK3 | 18133 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TAS2R14 | 14920 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| TBC1D2 | 18026 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TBC1D23 | 25622 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TBC1D30 | 29164 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| TBC1D4 | 19165 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| TC2N | 19859 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| TCEAL9 | 30084 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TCF7L1 | 11640 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TEC | 11719 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| TENM2 | 29943 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TESK1 | 11731 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TEX15 | 11738 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| TFAP2A | 11742 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TFPI2 | 11761 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| TGFA | 11765 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TGFBR1 | 11772 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TGFBR2 | 11773 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| THBS1 | 11785 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| THOC3 | 19072 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| THOC3 | 19072 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TIGD1 | 14523 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| TIMM22 | 17317 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TIMM23 | 17312 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TIMP1 | 11820 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| TIMP3 | 11822 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| TIMP3 | 11822 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| TINAGL1 | 19168 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| TIPARP | 23696 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TLE4 | 11840 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| TLR4 | 11850 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TM2D2 | 24127 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TMC5 | 22999 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| TMC7 | 23000 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TMCC3 | 29199 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| TMED7 | 24253 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TMEM14B | 21384 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| TMEM154 | 26489 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TMEM184B | 1310 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TMEM40 | 25620 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TMEM43 | 28472 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TMEM45A | 25480 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| TMEM45B | 25194 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| TMEM63A | 29118 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| TMEM75 | 32295 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| TMPRSS11D | 24059 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TMPRSS4 | 11878 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| TMTC3 | 26899 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TMTC4 | 25904 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| TNC | 5318 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| TNFAIP1 | 11894 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TNFAIP3 | 11896 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
| TNFRSF21 | 13469 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TNFSF10 | 11925 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| TNFSF15 | 11931 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| TNIK | 30765 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25881239
|
| TNIP1 | 16903 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TNS4 | 24352 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| TOX3 | 11972 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| TP63 | 15979 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| TPD52L1 | 12006 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| TPM4 | 12013 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
| TPRG1L | 27007 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TPST1 | 12020 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TRAF3IP2 | 1343 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TRAM2 | 16855 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| TRIM13 | 9976 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| TRIM2 | 15974 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| TRIM24 | 11812 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| TRIM29 | 17274 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
| TRIM33 | 16290 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| TSHZ2 | 13010 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| TSPAN14 | 23303 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TSPAN15 | 23298 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| TSPAN5 | 17753 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TSPAN7 | 11854 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| TSPAN8 | 11855 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| TSPYL5 | 29367 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| TTBK2 | 19141 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TTLL7 | 26242 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TUBA4A | 12407 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TUBB2A | 12412 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| TUBB2B | 30829 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TUBB6 | 20776 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| TXNDC16 | 19965 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
| TXNRD1 | 12437 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| UBASH3B | 29884 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| UBE3B | 13478 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| UBL3 | 12504 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| UBN2 | 21931 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| UCP2 | 12518 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| UGCG | 12524 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| UPP1 | 12576 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| USP9Y | 12633 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| VAMP3 | 12644 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| VAV2 | 12658 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| VCL | 12665 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| VCP | 12666 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
| VEGFC | 12682 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| VGLL1 | 20985 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| VIM | 12692 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.017 | 25881239
|
| VSNL1 | 12722 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| WDFY2 | 20482 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| WDR47 | 29141 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| WFDC2 | 15939 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
| WIPF2 | 30923 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| WLS | 30238 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| WNK3 | 14543 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| WNT7A | 12786 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
| WWTR1 | 24042 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| XBP1 | 12801 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| XDH | 12805 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| YIPF1 | 25231 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ZBED2 | 20710 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ZBTB38 | 26636 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ZBTB38 | 26636 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ZC3H6 | 24762 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ZDBF2 | 29313 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ZDHHC16 | 20714 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ZDHHC3 | 18470 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ZFHX3 | 777 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ZFP28 | 17801 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ZFP36L1 | 1107 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ZFY | 12870 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ZMYM1 | 26253 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ZMYM2 | 12989 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ZNF20 | 12992 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ZNF280B | 23022 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ZNF3 | 13089 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ZNF323 | 14097 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ZNF462 | 21684 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ZNF486 | 20807 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ZNF542P | 25393 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ZNF561 | 28684 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ZNF625 | 30571 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
| ZNF652 | 29147 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ZNF670 | 28167 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ZNF681 | 26457 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ZNF695 | 30954 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ZNF724 | 32460 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ZNF767P | 21884 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
| ZNF790 | 33114 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ZNF83 | 13158 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
| ZNF92 | 13168 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
| ZSCAN21 | 13104 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|